Reaction Details Report a problem with these data
Target
Kallikrein-1
Ligand
BDBM200209
Substrate
n/a
Meas. Tech.
In Vitro Inhibition Assay
IC50
7600±n/a nM
Citation
 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP Benzylamine derivatives as inhibitors of plasma kallikrein US Patent  US9234000 Publication Date 1/12/2016 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM200209
Synonyms:
US9234000, 200
Type:
Small organic molecule
Emp. Form.:
C35H36F2N4O4
Mol. Mass.:
614.6815
SMILES:
CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1
Structure:
Search PDB for entries with ligand similarity: